Search research articles
Contact Us
Filters
Showing results (71-80 of 318) with videos related to
Page
of 32
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism
|
November 10, 2004
Clinical endocrinology and metabolism. Regulation of energy homeostasis by peripheral signals
Stephen C Woods, Stephen C Benoit, Deborah J Clegg, et al.
Trends in Endocrinology and Metabolism: TEM
|
September 18, 2010
Obesity and leptin resistance: distinguishing cause from effect
Martin G Myers, Rudolph L Leibel, Randy J Seeley, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
A neural entero-pancreatic pathway that regulates insulin secretion and glucose tolerance
Madina Sokolov, Alejandro Tamayo, Noah J Levi, et al.
Endocrinology
|
July 20, 2002
Eating elicited by orexin-a, but not melanin-concentrating hormone, is opioid mediated
Deborah J Clegg, Ellen L Air, Stephen C Woods, et al.
Peptides
|
April 6, 2005
The role of previous exposure in the appetitive and consummatory effects of orexigenic neuropeptides
Stephen C Benoit, Deborah J Clegg, Stephen C Woods, et al.
Current Pharmaceutical Design
|
April 8, 2003
Insulin and the blood-brain barrier
Stephen C Woods, Randy J Seeley, Denis G Baskin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 15, 2007
The effects of the melanocortin agonist (MT-II) on subcutaneous and visceral adipose tissue in rodents
April D Strader, Haifei Shi, Ryuichi Ogawa, et al.
Nature Reviews. Endocrinology
|
June 8, 2011
GLP-1 and energy balance: an integrated model of short-term and long-term control
Jason G Barrera, Darleen A Sandoval, David A D'Alessio, et al.
The Journal of Nutrition
|
April 4, 2003
A controlled high-fat diet induces an obese syndrome in rats
Stephen C Woods, Randy J Seeley, Paul A Rushing, et al.
Eneuro
|
May 7, 2019
Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs
Annika Billefeld Bornebusch, Anders Fink-Jensen, Gitta Wörtwein, et al.
Page
of 32
Search research articles
Search
Showing results (71-80 of 318) with videos related to
Sort By:
Page
of 32
Best Practice & Research. Clinical Endocrinology & Metabolism
|
November 10, 2004
Clinical endocrinology and metabolism. Regulation of energy homeostasis by peripheral signals
Stephen C Woods, Stephen C Benoit, Deborah J Clegg, et al.
Trends in Endocrinology and Metabolism: TEM
|
September 18, 2010
Obesity and leptin resistance: distinguishing cause from effect
Martin G Myers, Rudolph L Leibel, Randy J Seeley, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
A neural entero-pancreatic pathway that regulates insulin secretion and glucose tolerance
Madina Sokolov, Alejandro Tamayo, Noah J Levi, et al.
Endocrinology
|
July 20, 2002
Eating elicited by orexin-a, but not melanin-concentrating hormone, is opioid mediated
Deborah J Clegg, Ellen L Air, Stephen C Woods, et al.
Peptides
|
April 6, 2005
The role of previous exposure in the appetitive and consummatory effects of orexigenic neuropeptides
Stephen C Benoit, Deborah J Clegg, Stephen C Woods, et al.
Current Pharmaceutical Design
|
April 8, 2003
Insulin and the blood-brain barrier
Stephen C Woods, Randy J Seeley, Denis G Baskin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 15, 2007
The effects of the melanocortin agonist (MT-II) on subcutaneous and visceral adipose tissue in rodents
April D Strader, Haifei Shi, Ryuichi Ogawa, et al.
Nature Reviews. Endocrinology
|
June 8, 2011
GLP-1 and energy balance: an integrated model of short-term and long-term control
Jason G Barrera, Darleen A Sandoval, David A D'Alessio, et al.
The Journal of Nutrition
|
April 4, 2003
A controlled high-fat diet induces an obese syndrome in rats
Stephen C Woods, Randy J Seeley, Paul A Rushing, et al.
Eneuro
|
May 7, 2019
Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs
Annika Billefeld Bornebusch, Anders Fink-Jensen, Gitta Wörtwein, et al.
Page
of 32